Pfizer's late-stage coronavirus vaccine trial is near complete enrollment with 42,000 volunteers

3
In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.
University of Maryland School of Medicine | AP

Pfizer‘s late-stage coronavirus vaccine trial has enrolled more than 42,000 volunteers, the company announced Tuesday when it released a mixed third-quarter earnings report.

Nearly 36,000 of the volunteers have already received the second of the company’s two-dose Covid-19 vaccine, the company said.

This is a developing story. Please check back for updates.

View original post